Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
cancer immunotherapy
deals
detroit blog main
detroit top stories
eli lilly
3
×
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aduro biotech
agenus
alzheimer's disease
biogen
bristol-myers squibb
car-t immunotherapy
What
bio
companies
3
×
drug
3
×
roundup
nash
news
price
alzheimer’s
approval
approved
biogen’s
biopharmaceutical
convo
different
digital
disease
earlier
epidemic
fail
failures
fatty
fda
frenzied
gene
growing
increases
known
latest
led
littered
liver
merck
new
pharmaceutical
plan
prescription
prices
race
raise
remains
Language
Current search:
cancer
×
drug
×
national
×
companies
×
" eli lilly "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More